Notices

NABL certificate for CSIR-CDRI New

Call for R&D Proposals from Industry & Start Ups for breakthrough technological interventions against COVID-19 New

Guesthouse booking has now been suspended till further notice in view of COVID-19 New

CDRI AWARDS - 2020 for Excellence in Drug Research New

Skill Development Program on Basic Training in Electron Microscopy techniques for Life Sciences New

Skill Development Program on Pathological Tools & Techniques for Biomedical Applications New

Name of candidates who Shortlisted by Screening Committee for the one position of Programme Coordinator of Coordinating Cell, MoES against the Advertisement No. 02/2020. New

Partial modification in Advt. No. 03/2020 regarding Remuneration for one position of Consultant (SO) in F&A in CSIR-CDRI. New

Result of project staff against advertisement number 01/2020 New

Notice Regarding Walk-in-Interview of advertisement No 04/2020 for the Post of Part Time Doctor New

Tentative list of Shortlisted & Rejected candidate for the post of scientist/ Sr. Scientist/ Pr. Scientist against advt no- 07/2019 New

Skill Development Program on Certificate course on Computational Approaches to Drug Design and Development New

Invitation to participate in "AcSIR - Gyantarang-2020" New

Invitation for Nomination / Application for CDRI AWARDS 2020 for Excellence in Drug Research | Download Application Form New

A unique opportunity for research career in Science & Technology in the area of Drugs, Pharmaceuticals and Biomedical ResearchNew

Tender for SUPPLY OF CARBON MOLECULER SIEVE GRADE F PELLETNew

Tender for Supply of SMOKE/PARTICLE EXPOSE CHAMBER New

Tender for Supply of Fruits and VegetablesNew

Tender for Supply of Green Doob GrassNew

Corrigendum reg. correction in date in Rate contract 2020-2021 tender New

Tender for Housekeeping and Maintenance of Guest House and Providing of Catering Services New

Tender inquiry for Rate contract 2020-2021 for Consumables New

Corrigendum for Re-Tender ID: 2020_CSIR_52184_1 dted 03-07-2020 New

Corrigendum for Cancellation of the Tender ID: 2020_CSIR_52060_1 dted 03-07-2020 New

Tender for Supply of RHEOMETER New

Tender for Supply of PCR machine with dual 48/48 Fast Reaction Module with accessories New

Tender for Supply of Smoke Chamber consist Of One Air Chamber, One Smoke Chamber And One Animal Chamber New

Supply of Rotary Evaporator with Chiller and Vacume Pump New

Extension of Rate Contract 2019-20 for 3 months New

Annual Job Contract for up keeping Horticulture & allied work New

PO Order regarding items End repair/Da tailing module (L) 1, Quick ligation module(S) 1... New

Tender for Supply of Orbital Shaker as per tender document New

Tender for High Pressure Liquid Chromatography New

Supply of Nanodrop/Nanovolume Spectrophotometer with Cuvette applications New

Supply of sonicater as per specification in the tender document New

Supply of biomolecule imager as per technical specification Attached New

Cancellation of Tender New

Cancellation of Tender New

Supply of High Pressure Liquid Chromatography New

Empanelment of Service Provider/s for cGMP manufacture of Investigational New Drugs and their Formulations for Clinical Trials New

Supply of Peristaltic Pump New

Corrigendum regarding Date Extension and Bidder Inclusion for tender of Multimode Microplate Reader New

Tender for Rotary Evaporator Bundled With The Vaccump pump and recirculating chiller New

Corrigendum regarding Date Extension and Clarification for cGMP manufacture of investigational new drugs and their formulation for clinical trials/services New

Tender for Supply of GC-FID-MS System New

Supply of UPLC Syatem New

Geneal Terms & Conditions for Tender

GST Certificate

Please Visit Central Public Procurement Portal (CPP Portal.) for CDRI Tenders


Message from Director


Prof. Tapas K. Kundu

Director, CSIR-CDRI

Welcome to the new website of CSIR-Central Drug Research Institute (CSIR-CDRI), a premier institute which has achieved seamless integration of basic and translational research, and evolved as aunique state run comprehensive centre for drug research and development in Asian continent. Sixty-acre new campus, comprising of laboratory complex and R&D support facilities, provide a vibrant atmosphere for multidisciplinary R&D and human resource development. Read More...


Research Area

CDRI
CSIR-CDRI

Development of new drugs/drug combinations as therapeutic interventions for malaria, leishmaniasis and filariasis

Development of new drugs/drug combinations as therapeutic intervention for malaria, leishmanial and filariasis


Identification of unique targets and pathways for future interventions


Investigations on parasite biology and host-parasite interactions.

CDRI
CSIR-CDRI

Synthesis, Biological Evaluation, Structure−Activity Relationship and Mechanism of Action Studies of Quinoline-metronidazole Derivatives against Experimental Visceral..

To identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline-metronidazole was synthesized and tested against murine model of visceral leishmaniasis.Among all synthesized derivatives, 15b and 15i showed promising antileishmanial efficacy against both extracellular promastigote (IC50 9.54 µM and 5.42 µM respectively) and intracellular amastigote (IC50 9.81 µM and 3.75 µM respectively) form of L. donovani with negligible cytotoxicity towards host.

cdri
CSIR-CDRI

Development of novel agents for fracture healing and management of osteoporosis through modern drug design..

Development of novel agents for fracture healing and management of osteoporosis through modern drug design, scientific validation of traditional remedies and generation of new knowledge

CDRI
cdri

The World Health Organization has defined Antimicrobial resistance as the ability of a microorganism to stop an antimicrobial from working against it..

The World Health Organization(WHO) has defined Antimicrobial resistance (AMR) as the ability of a microorganism to stop an antimicrobial from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others. It has further stated “AMR is of particular concern in developing nations, including India, where the burden of infectious disease is high and healthcare spending is low. The country has among the highest bacterial disease burden in the world. Antibiotics, therefore, have a critical role in limiting morbidity and mortality in the country.

CDRI
CSIR-CDRI

Affordable drugs for lifestyle diseases (CVS,CNS and related disorders) to achieve the dream “SWASTH BHARAT”

As per the estimates in the WHO non communicable disease (NCD) Country Profile 2014, Cardio- vascular disease (CVD) is the leading cause of Deaths in India and accounts for 26% of all deaths. As per WHO more than 4% of Indian population (3rd in world after USA and China) is obese, which is the main reason of major CVDs. In 2008, WHO declared dementia/AD as a priority condition through the Mental Health Gap Action Programs


cdri
CSIR-CDRI

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female)..

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female) and management of endocrine disorders through modern drug design, scientific validation of traditional remedies

CDRI
cdri

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn ...

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn metamorphose to flagellated spermatozoa that mature in the epididymis. To characterize the dynamics of gene expression during these important stages of spermatogenesis, undertook transcriptome analysis in >90% pure pachytene spermatocytes and round spermatids, and pure mature sperm of rat by massive parallel deep sequencing.

CDRI
CSIR-CDRI

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

cdri
cdri

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance..

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance, international relevance and public health needs


Continued engagement with drug regulation and pharmaceutical policy making in India as well as internationally

Our Drugs

E-MAL Arteether

For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.

Keen Mind Bacopa Extract

Keenmind is marketed through Soho Flordis International, Sydney, Australia and is available now in India.

Saheli Centchroman

First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.

Reunion Dalzbone

Success Story of Development of New Herbal Medication for Bone Health.


MoUs/Licenses

Facilities & Services

Events & Activities


Campus Life@ CDRI



Important Links

Style Switcher